Compound ID | 1951
Class: Beta-lactam (aminopenicillin)
| Spectrum of activity: | Gram-positive & Gram-negative | 
| Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Active against Gram-positive bacteria and some Enterobacteriaceae, but vulnerable to penicillinases produced by staphylococci and E. coli | 
| Description: | Semisynthetic penicillin, derived from 6-aminopenicillanic acid (6-APA), ampicillin-ester. Oral application | 
| Institute where first reported: | Pfizer | 
| Year first mentioned: | 1975 | 
| Highest developmental phase: | Approved by FDA in 1980 | 
| Development status: | Discontinued | 
| Chemical structure(s): | |||||||||||
| 
 | 
 | 
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/441397 | 
| Guide to Pharmacology: | bacampicillin | 
| Citations: |  |